Copyright Reports & Markets. All rights reserved.

USA Rotavirus Vaccine Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Rotavirus Vaccine Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Pentavalent Oral Market Performance (Volume)
      • 2.1.2 Oral Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Pentavalent Oral Market Performance (Value)
      • 2.1.2 Oral Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Government Institution Market Performance (Volume)
      • 3.1.2 Private Sector Market Performance (Volume)
      • 3.1.3 Other Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Astellas Pharma
      • 4.1.1 Astellas Pharma Profiles
      • 4.1.2 Astellas Pharma Product Information
      • 4.1.3 Astellas Pharma Rotavirus Vaccine Business Performance
      • 4.1.4 Astellas Pharma Rotavirus Vaccine Business Development and Market Status
    • 4.2 CSL Limited
      • 4.2.1 CSL Limited Profiles
      • 4.2.2 CSL Limited Product Information
      • 4.2.3 CSL Limited Rotavirus Vaccine Business Performance
      • 4.2.4 CSL Limited Rotavirus Vaccine Business Development and Market Status
    • 4.3 Emergent BioSolutions
      • 4.3.1 Emergent BioSolutions Profiles
      • 4.3.2 Emergent BioSolutions Product Information
      • 4.3.3 Emergent BioSolutions Rotavirus Vaccine Business Performance
      • 4.3.4 Emergent BioSolutions Rotavirus Vaccine Business Development and Market Status
    • 4.4 GlaxoSmithKline
      • 4.4.1 GlaxoSmithKline Profiles
      • 4.4.2 GlaxoSmithKline Product Information
      • 4.4.3 GlaxoSmithKline Rotavirus Vaccine Business Performance
      • 4.4.4 GlaxoSmithKline Rotavirus Vaccine Business Development and Market Status
    • 4.5 Johnson&Johnson
      • 4.5.1 Johnson&Johnson Profiles
      • 4.5.2 Johnson&Johnson Product Information
      • 4.5.3 Johnson&Johnson Rotavirus Vaccine Business Performance
      • 4.5.4 Johnson&Johnson Rotavirus Vaccine Business Development and Market Status
    • 4.6 MedImmune
      • 4.6.1 MedImmune Profiles
      • 4.6.2 MedImmune Product Information
      • 4.6.3 MedImmune Rotavirus Vaccine Business Performance
      • 4.6.4 MedImmune Rotavirus Vaccine Business Development and Market Status
    • 4.7 Merck
      • 4.7.1 Merck Profiles
      • 4.7.2 Merck Product Information
      • 4.7.3 Merck Rotavirus Vaccine Business Performance
      • 4.7.4 Merck Rotavirus Vaccine Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 USA Rotavirus Vaccine Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 USA Rotavirus Vaccine Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 USA Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 USA Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Northeast Market Performance for Manufacturers
      • 6.1.1 Northeast Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Northeast Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Northeast Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Northeast Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 Midwest Market Performance for Manufacturers
      • 6.2.1 Midwest Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 Midwest Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 Midwest Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 Midwest Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 South Market Performance for Manufacturers
      • 6.3.1 South Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 South Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 South Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 South Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 West Market Performance for Manufacturers
      • 6.4.1 West Rotavirus Vaccine Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 West Rotavirus Vaccine Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 West Rotavirus Vaccine Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 West Rotavirus Vaccine Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration

    7 USA Rotavirus Vaccine Market Performance (Sales Point)

    • 7.1 USA Rotavirus Vaccine Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 USA Rotavirus Vaccine Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 USA Rotavirus Vaccine Price (USD/Unit) by Regions 2013-2018
    • 7.4 USA Rotavirus Vaccine Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 USA Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Northeast Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 Midwest Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 South Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 West Rotavirus Vaccine Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Government Institution Industry
    • 11.2 Private Sector Industry
    • 11.3 Other Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 USA Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 USA Rotavirus Vaccine Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Northeast Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 Midwest Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 South Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 West Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.10 Rotavirus Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Pentavalent Oral Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Oral Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Government Institution Sales and and Growth Rate 2019-2024
      • 12.4.3 Private Sector Sales and and Growth Rate 2019-2024
      • 12.4.4 Other Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 USA Rotavirus Vaccine Price (USD/Unit) Trend 2019-2024
      • 12.5.2 USA Rotavirus Vaccine Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Rotavirus Vaccine for these regions, from 2012 to 2023 (forecast), including
    Northeast
    Midwest
    South
    West

    USA Rotavirus Vaccine market competition by top manufacturers/players, with Rotavirus Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Astellas Pharma
    CSL Limited
    Emergent BioSolutions
    GlaxoSmithKline
    Johnson&Johnson
    MedImmune
    Merck
    ...

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Pentavalent Oral
    Oral

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Rotavirus Vaccine for each application, including
    Government Institution
    Private Sector
    Other

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now